| Website | ivantisinc.com |
| Category | BioTech |
| Phone | 949-600-9650 |
| Employees |
| TOTAL | $17M |
| VENTURE FUNDING TOTAL | $17M |
| Series B, 6/11 New Enterprise Associates Delphi Ventures | $17M |
Ivantis, Inc. is a company focused on developing an innovative treatment for Glaucoma. It is their goal to develop a less invasive, more effective option for the 60+ million people worldwide suffering from Primary Open Angle Glaucoma. As they successfully address this initial goal, it is then there intention to focus on innovative development for the treatment of other debilitating diseases within ophthalmology.
